India's largest platform and marketplace for GCC & AI leaders and professionals

Sign in

India's largest platform and marketplace for GCC & AI leaders and professionals

3AI Digital Library

CES 2021 conference stress importance of security education

3AI January 22, 2021

Experts at the CES 2021 conference stress importance of security education

Picture from freepik.com

    3AI Trending Articles

  • Establishing Effective Text Data with Sentiment Analysis

    Featured Article Author: Vinoth Nageshwaran, Business Insider Establishing effective text data frameworks with sentiment analysis is essential for organizations looking to derive meaningful insights from textual information. Sentiment analysis, a subset of natural language processing (NLP), involves identifying and categorizing opinions expressed in text to determine the sentiment behind them. This technique is invaluable for […]

  • Way to make object-recognition models perform better

    Adding a module that mimics part of the brain can prevent common errors made by computer vision models. Computer vision models known as convolutional neural networks can be trained to recognize objects nearly as accurately as humans do. However, these models have one significant flaw: Very small changes to an image, which would be nearly […]

  • A peek into how AI will dominate functioning of Next Gen GBS

    Author: Saswata Kar, Head – Analytics & Data Sciences, Philips GBS | LinkedIn – https://www.linkedin.com/in/saswata-kar-95b9074/ Global Business Services or GBS is the collective name given to centralized hubs where big corporations have moved processes that can benefit from centralization, standardization, and automation. The location for these centers is largely governed by cost considerations and talent […]

  • AI in Drug Discovery

    Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]